Home > News > NCL to go into labs with ‘Golden Triangle’ for cancer trials
May 30th, 2005
NCL to go into labs with ‘Golden Triangle’ for cancer trials
Eight months after raising hopes with their cutting edge ‘Golden Triangle’ technology for fighting cancer sans chemotherapy, nanoscientists at the National Chemical Laboratory (NCL) are gearing up for the technology’s first in-vitro tests.
The trials are being conducted to establish the toxicity of the gold nano-particles. "While gold is inherently non-toxic, we have to see exactly where the nano-sized triangles go when introduced into the cancerous area. We have kept a two-year window to see if we can get into clinical trials on humans."
National Chemical Laboratory
MANA Research Highlight: Smart nanofibers to treat kidney failure March 6th, 2014
Harris & Harris Group, Inc. Establishes and Invests $350,001 in ProMuc, Inc. March 6th, 2014
First Look at How Individual Staphylococcus Cells Adhere to Nanostructures Could Lead to New Ways to Thwart Infections: Berkeley Lab-led research could guide the development of bacteria-resistant materials March 5th, 2014
Dartmouth Researchers Find Promising Results with Local Hyperthermia of Tumors March 4th, 2014
Nanopositioning Stage & Digital Controller for Imaging, Surface Metrology and Microscopy Available from PI March 6th, 2014
Elmarco Enabled Industrial Electrospinning Technology for Laboratories: Elmarco introduces NS LAB, the electrospinning research tool designed for the needs of universities and research institutes March 6th, 2014
New Data Model Boosts Space Science March 6th, 2014
Carbodeon NanoDiamonds PTFE Coating doubles surface durability and reduces friction by up to 66 percent: New surface coating enables cost-effective CO2 and fuel reductions in machinery March 6th, 2014